Merck has invested 500 million euros to develop its Semiconductor Solutions mega site in Kaohsiung, Taiwan. With this move, the company aims to strengthen its global supply chain resilience.

With a double-digit million-euro investment, BASF Agricultural Solutions has commissioned a new fermentation plant for biological and biotechnology-based crop protection products at its Ludwigshafen site in Germany.

Under a MOU signed between BASF and Sevnce Robotics, both the companies will explore potential applications of Sevnce’s robotic and intelligent inspection solutions at BASF sites.

Dedicated policies and initiatives encouraging the use of clean, sustainable and smart technologies are already being implemented across the Middle East. These revolutionary changes are all set to empower the region.

Zeon Corporation has partnered with Chemify for accelerating the design, discovery, and synthesis of novel molecules for medicines and advanced materials.

Few industries are as diverse as the water and environmental sector. Keller Pressure sensors are used in a wide variety of applications in this sector. For example, they are utilized to determine flow rates and regulate water levels.

Under a strategic collaboration with Nvidia, Thermo Fisher Scientific will make use of Artificial Intelligence (AI) to advance scientific instrumentation and accelerate laboratory performance.

Saudi Aramco Total Refining and Petrochemical Company (Satorp) has awarded a seven-year General Maintenance Services contract to KBR, with a three-year extension option for its strategic petrochemical expansion complex in Jubail, Saudi Arabia.

A leading coatings manufacturer in Wales has installed an advanced online gas analysis system to monitor emissions of Volatile Organic Compounds (VOCs), enabling the company to leverage real-time data for measurable environmental, operational and compliance benefits.

GSK has plans to takeover Nuvalent, a Boston-based clinical-stage biopharmaceutical company for 10.6 billion dollars. The biopharmaceutical firm is focused on creating precisely targeted oncology therapies.